Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7378669 | 1.00 | HRH3 (0.56) | HRH3TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL7383124 | 0.82 | SLC6A3 (0.53) | HRH3 | |
| SCHEMBL7383126 | 0.82 | SLC6A3 (0.53) | HRH3 | |
| SCHEMBL7385271 | 0.79 | MAOA (0.53) | — | |
| SCHEMBL7377219 | 0.79 | SIGMAR1 (0.39) | HRH3L3MBTL1THRB | |
| SCHEMBL7377224 | 0.79 | SIGMAR1 (0.39) | HRH3L3MBTL1THRB | |
| SCHEMBL7385263 | 0.79 | MAOA (0.53) | — | |
| SCHEMBL16026648 | 0.75 | HRH3 (0.84) | HRH3TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL7379983 | 0.72 | SIGMAR1 (0.63) | CYP1A2 | |
| SCHEMBL7379985 | 0.72 | SIGMAR1 (0.63) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5409929-A | Treating psychosis, dyskinesia | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-25 | — | — | US | disclosed |
| US-5216018-A | Antidyskinetic agents | DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-06-01 | — | — | US | disclosed |